Motivational Interviewing Course: Assisting Patients in Making Sustainable Positive Lifestyle Changes

We invite you to register for this free webinar-based training course on Motivational Interviewing (MI). The three week long series is presented by Igor Koutsenok, MD, MS, Professor of Psychiatry at the University of California San Diego, Department of Psychiatry.

Igor Koutsenok ISSUP Motivational Interviewing

Motivational Interviewing is an essential, client-centered, counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence. We are absolutely thrilled to bring you this skills-building opportunity presented by a recognized expert in the field of MI.

The course consists of four sessions to be held during June 2020 (see course descriptions and session dates below).

We highly encourage registration for all sessions.

Course Description

This is a training in evidence-based clinical methods of motivational interviewing (MI). After orientation to the underlying spirit and principles of MI, practical exercises will help participants to strengthen empathy skills, recognize and elicit change talk, and roll with resistance. Research evidence will be reviewed for the efficacy of MI and for the importance of building therapeutic relationships in clients’ outcomes. Integration of MI with other treatment modalities will be considered.     

Course Objectives

The goal is to provide knowledge and practical skill training for various practitioners on effective ways to enhance motivation of patients with substance use disorders that require significant behavioral changes to initiate and sustain positive and healthy behavioral choices. Skill building, and experiential training will be emphasized throughout the course by exercises to develop a therapeutic alliance with patients, assess patient needs, level of engagement in treatment process, structure treatment sessions, select appropriate interventions, and assist patient in maintaining motivation for a sustainable behavioral change.

Participants will learn the basic and advanced skills in motivational interviewing and strategies for engaging patients in collaborative relationship in treatment process and assist them in achieving sustainable positive behavioral changes. The course will:

  1. Help participants to acquire a systemic perspective of motivational interviewing and other motivational enhancement strategies;
  2. Build necessary clinical skills and attitudes to implement new strategies in working with ambivalent patients.

Learning Outcomes

Upon completion of the course, every participant will be able to:

  1. Describe all the aspects of the spirit of MI
  2. Explain the differences between MI and other counselling strategies
  3. Demonstrate the ability to respond to clients with reflective listening statements
  4. Identify change talk within client speech
  5. Generate open questions designed to elicit change talk
  6. Generate MI-consistent responses to client resistant statements
  7. Differentiate commitment language from other forms of change talk
  8. Provide and empathetic summary statements collecting change talk

Course Content, Dates & Registration

Session 1: Thursday June 4th 2020

Motivational Interviewing: Basic Understanding

After orientation to the underlying spirit and principles of MI, practical exercises will help participants to strengthen empathy skills, recognize and elicit change talk, and roll with resistance. Research evidence will be reviewed for the efficacy of MI and for the importance of building a therapeutic relationship in clients’ outcomes. Integration of MI with other treatment modalities will be considered.  

Learning outcomes:

  • Introduction: Motivation and behavioral change in addiction medicine
  • Review of the concepts of Ambivalence, Stages of change, the righting reflex, limits of persuasion.
  • Spirit of MI
  • Expressing empathy
  • Roadblocks to communication
  • Four Processes in MI

Time: 9am Pacific / 12pm Eastern / 5pm London

Duration: 1 hour

Webinar Recording 

Slide Deck

Session 2: Thursday June 11th 2020

Fundamental Skills in MI - OARS

This session will focus on Fundamental Skills in MI (OARS), providing practical exercises to help participants to strengthen empathy skills, recognize and elicit change talk, and roll with resistance. Participants will learn strategies for engaging patients in a collaborative relationship in the treatment process and assist them in achieving sustainable positive behavioral changes. Research evidence will be reviewed for the efficacy of MI and for the importance of building a therapeutic relationship in clients’ outcomes. Integration of MI with other treatment modalities will be considered.    

Learning outcomes:

  • Open and closed ended questions
  • Affirmations
  • Summaries
  • Rowing with OARS

Time: 9am Pacific / 12pm Eastern / 5pm London

Duration: 1 hour

Webinar recording

Session 3: Thursday June 18th 2020

Fundamental Skills in MI Continued

This third session will continue to focus on MI fundamentals, with a focus on more advanced skills and the integration of MI with other strategies and treatment modalities. Research evidence will be reviewed for the efficacy of MI and for the importance of building therapeutic relationship in clients’ outcomes.       

Learning outcomes:

  • Recognition and responding to change talk and sustain talk
  • Forming reflections
  • Levels of reflections
  • Recognizing readiness
  • Initial and intermediate planning
  • Integration with other skills and strategies

Time: 9am Pacific / 12pm Eastern / 5pm London

Duration: 1 hour

Webinar recording 

Session 4: Friday June 19th 2020

The fourth and final session will continue to build on MI Fundamentals covered in Session 3, increasing your knowledge of advanced MI skills.

Time: 9am Pacific / 12pm Eastern / 5pm London

Duration: 1 hour

Webinar recording 

We look forward to you joining us for these virtual sessions! Please contact info [at] issup [dot] net if you have any questions.

About Professor Koutsenok

Dr. Igor Koutsenok is а Professor of Psychiatry at the University of California San Diego, Director of the Center for Addiction Research, Training and Application, Director of the SAMHSA PEPFAR International Addiction Technology Transfer Center-Ukraine, and a co-director of the SAMHSA PEPFAR South East Asia Addiction Technology Transfer Center. He is also a Vice-President of the International Consortium of Universities on Drug Demand Reduction.

In 1983 he graduated as a medical doctor from the National Medical University in Kiev, (Ukraine). In 1986, he completed his psychiatry residency training and received degree as psychiatrist from the Medical University in Sofia (Bulgaria). In 1993-1996 he received a degree in addiction psychiatry at the University of London, Department of Addictive Behavior and Psychological Medicine at St. Georges Hospital Medical School. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member of the Department. In 2013-2016 he served as Chief of Prevention, Treatment, and Rehabilitation at the United Nations Office on Drugs and Crime, United Nations Office in Vienna.

Over the last 25 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for mental health and addiction treatment practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. He is also directing the UCSD Summer Clinical Institute - the second longest running Summer Institute in the United States (over 40 years). Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). 

For many years, Dr. Koutsenok taught general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 50 scientific publications, one monograph, and contributed to 4 book. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.

Full Tuition Scholarship to the Virtual 49th Summer Clinical Institute in Addictions Studies 2020

The University of California San Diego, School of Medicine, Department of Psychiatry, is honored to award you with a full tuition scholarship to the virtual 49th Summer Clinical Institute in Addictions Studies 2020.

You will have a chance to interact and learn from the world leading experts , scientists, practitioners and policy makers in the area of Substance Use Disorders. We would like to thank the Scaife Family Foundation for their continues support of the institute, particularly scholarships for students and trainees.

The Institute will be held on June 2 & 3.

Please visit the secure scholarship link to register online and confirm your acceptance and attendance by May 30, 2020.

(Note: A unique registration is required for each attendee.)

If you are in need of Continuing Education Units (13 available) please process your payment for CEU fees upon your registration. 

Best Practices for Co-occurring Disorders Treatment: Staffing and Training

Event Date
City/Region/State
Webinar

Presented by: Great Lakes, Northeast & Caribbean, and Northwest Addiction Technology Transfer Centers (ATTCs)

Organizational staffing directly impacts program capacity for integrated treatment, particularly whether an organization’s staff composition includes staff with dual licensure or extensive experience treating individuals with co-occurring disorders. This webinar will address strategies for staffing, supervision, and training that can contribute to an improved infrastructure and ongoing staff development that will enhance integrated care.

Time: Aug 19, 2020 10:00 AM in Pacific Time (US and Canada)

Treatment Improvement Protocol 63: Medications for Opioid Use Disorder

The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery.

Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. 

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

NAADAC COVID-19 Resource List

Health care professionals around the world are fighting tirelessly to reduce the harm that is being caused by COVID-19.

Several public health organisations are creating and updating resources so that people can be updated on the changing situation and can use the knowledge to inform and adjust their practice.

NAADAC has brought together a selection of resources that offer both a general overview of the current climate as well as specific advice for health care professionals working in the DDR field.

Resources are grouped under the following headings:

Drugs of Abuse Resource Guide

Education plays a critical role in preventing substance abuse.

Drugs of Abuse, a DEA Resource Guide, is designed to be a reliable resource on the most commonly abused and misused drugs in the United States.

This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts.

As well as providing information on all the major drug classes, the resource guide describes the Controlled Substance Act and provides information on U.S. chemical control.

Supporting the Families of Substance Users: An Interview with Vivienne Evans OBE

Event Date
City/Region/State
London
Country
United Kingdom

Register for the next webinar in the ISSUP Expert days series:

ISSUP Expert Days

Please join us on Friday 24th of April at 2pm (GMT) for an interview with Vivienne Evans OBE, ISSUP Board member and Chief Executive of Adfam - the UK’s national umbrella organisation for children and families affected by substance misuse. Adfam’s mission is to empower family members and carers, supporting frontline workers and influencing decision-makers to stop drug and alcohol use from threatening and ultimately destroying family relationships and wellbeing.

Recent research published by Adfam revealed that almost 1 in 3 adults in the UK have been negatively affected by the substance use of someone they know, including family members. Many families suffer in silence without access to adequate support. The harms can range from mental health problems, abuse, relationship difficulties, financial strain and isolation to many other forms of stigma.

What ways can you inform your practice to improve outcomes for families? How should you approach the provision of ongoing support for children affected by parental substance misuse? How can providers ensure families are given the necessary opportunities to recover and thrive? What strategies can you use to help families overcome stigma and find the confidence to access the support they need?

Vivienne will be helping participants to navigate these questions and more. You will learn how to offer effective support to enable families to improve their health and wellbeing, stay in work, participate in society and build and maintain positive relationships.

About Vivienne

Vivienne Evans OBE is the Chief Executive of Adfam and has extensive background experience in drug and alcohol education, prevention and working with young people. She is a former member of the Advisory Council on the Misuse of Drugs (ACMD) and chaired its working group on the implementation of Hidden Harm.  She also chaired the Drug Sector Skills Consortium, funded by the Department of Health, from 2012 until its conclusion in 2015. For more information about ADFAM and its work with families and professionals, visit: https://adfam.org.uk/

How to join the webinar

Step 1: Register

First click here and register to book your place on the webinar. There are limited places available and only registered users will have access to the webinar. All you have to do is click here to save your place. Plus, we'll send you a link to watch the recording at your leisure after the live session.

Step 2: Join the webinar

After you have registered for the webinar you will receive instructions on how to join at the specified time.

Event Language

English

WEBINAR: Cary Hopkins Eyles on Authentic Self-Care for Addiction Professionals

This webinar focuses on the issue of self-care for addiction professionals and was delivered by ICUDDR Deputy Director Cary Hopkins Eyles.

Many of us are drawn to work in the field of substance use disorders due to our history, family, and personal traits, such as compassion and empathy. While these can be great assets, they can also be detrimental to us personally.

In this webinar, Cary explains how to identify healthy and unhealthy traits, how we can care for ourselves, and what authentic self-care looks like.

Cary has worked in the field of substance use disorders for 18 years. She is passionate about helping professionals in this field to take care of themselves so they can thrive and help those in need. Cary has worked in direct care in non-profit in the U.S., has run Residential, Outpatient, and Criminal Justice treatment programs, and has trained and mentored other substance use professionals. She is now the Deputy Director for the International Consortium of Universities for Drug Demand Reduction (ICUDDR) and supports the development of addiction studies programs around the world. She is a global trainer in the Universal Treatment Curriculum (UTC).

Recorded on 13 March 2020

Cary Hopkins Eyles

McLean Hospital Addictions Conference 2020

Event Date
City/Region/State
Boston

Harvard Medical School and McLean Hospital are pleased to offer this intensive 2-day course which brings together some of the foremost authorities in the addiction field.

Topics will include new, evidence-based treatments, the nuances of treating co-occurring disorders along with addiction, and special populations. Smaller breakout sessions allow for in-depth exploration of topic areas in an interactive and stimulating format that should enhance learning and skill-building.

Because alcohol and drug misuse have so many dimensions and disrupt so many aspects of an individual’s life, treatment is never simple. To effectively help the people seeking your guidance, it can be invaluable to take time from your busy practise to update your knowledge and skills around all of these complex areas and treatment strategies. This conference consolidates all of the latest information and helps you apply it in the office when you return.

NAM Action Collaborative Webinar on Countering the U.S. Opioid Epidemic

Event Date
City/Region/State
Washington DC
Country
United States

Tuesday, March 10, 2020, 3:00 PM – 5:30 PM EDT (the US)

TO REGISTER NOW, PLEASE CLICK HERE

 

Caring for Patients with Chronic Pain

The listening session aims to collect input on the state of chronic pain management and bring greater awareness to any intended and unintended consequences of recent changes to opioid prescribing guidelines and related metrics, as they pertain to the delivery, access, and coordination of chronic pain management and care.

This session is structured as a guided discussion with a diverse panel of clinicians, who treat and manage the care of patients with chronic, non-cancer pain. 

The discussion will inform the creation of a person-centered pain management journey map—a visual illustration of a chronic pain management journey—that will serve to accelerate the uptake of a range of pain treatments by outlining approaches to effective communication that lead to strong clinical relationships and optimal quality of life for people with chronic pain. 

There is also an opportunity to contribute to the listening session discussion by providing written responses to the discussion questions via this form. The form will remain available for two weeks following the listening session and is an opportunity to directly inform the work of the NAM's Action Collaborative on Countering the U.S. Opioid Epidemic. We encourage you to share this opportunity for input with your network.

Event Language

English

Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States

Opioid use and Opioid Use Disorder (OUD) continues to be a significant public health concern in the United States.

Several medications for OUD (MOUDs) are now considered by the medical community to be the criterion standard in OUD recovery

While many individuals with opioid use disorder seek treatment at residential facilities to initiate long-term recovery, the availability and use of MOUDs in these facilities are unclear.

A recent cross-sectional study, published in JAMA Network, has examined whether residential addiction treatment facilities in the United States use medications for opioid use disorder (MOUDs).

The researchers examined admission data from 2863 residential treatment facilities in 2017.

Results from the study found that:

  • Most residential facilities (i.e., 60.0%) in the United States did not offer any Food and Drug Administration–approved MOUDs in 2017 
  • Patients admitted to residential facilities that expanded Medicaid were more likely to have MOUDs as part of their treatment compared to those without expanded Medicaid.
  • MOUD prescriber restrictions for Medicaid reimbursement were further linked with MOUD use.

Overall the researchers conclude that

While residential treatment facilities may offer a high level of behavioural treatment in a structured environment, this study indicates that access to MOUDs for patients in these facilities is lacking.

In practical terms, the researchers suggest;

Medicaid expansion and the relaxation of MOUD prescribing restrictions for Medicaid reimbursement could improve MOUD availability and use in residential facilities.

Viewing the Opioid Epidemic in Rural Communities through the Lens of Prevention

Event Date
City/Region/State
Washington
Country
United States

Join the Prevention Technology Transfer Center (PTTC) Network 

Tuesday, March 17, 2020

2:00 pm - 3:30 pm EST

In spring 2015, the HIV outbreak caused by injection drug use in rural Scott County, Indiana, USA, made headlines around the world. More than 200 cases were confirmed in the town of Austin, affecting one-fifth of its population of 4,200. This rural county faced multiple challenges in addressing the outbreak: poverty, high unemployment, and limited access to medical care, compounded by a devastating shortage of substance use disorder treatment and recovery services.
 
Today, nearly all the people who contracted HIV during the 2015 outbreak are virally suppressed. In just four years, the number of people in recovery has increased by 1000%, new Hepatitis C cases are declining, and new HIV cases have plummeted by over 97% to just 5 in 2018.
 
In this 1.5 hour webinar, Dr. Ryan Westergaard of the University of Wisconsin School of Medicine and Public Health shares insights on some of the upstream life events, traumas, and challenges that may contribute to opioid misuse for people living in rural communities. Dr. Will Cooke of Scott County will provide an overview of the community-based approach that is helping to reclaim the lives of people with opioid use disorder and transform Scott County.

Event Language

English

ISAM – CSAM Joint Conference 2020

Event Date
City/Region/State
Victoria
Country
Canada

The International Society of Addiction Medicine [ISAM] and the Canadian Society of Addiction Medicine [CSAM-SMCA] (La societe medicale canadienne sur l’addiction) invites your organization to be part of our joint Annual Meeting and Scientific Conference November 12-14, 2020 in beautiful Victoria, BC, Canada.

The 2020 conference will highlight new research findings, sociopolitical ideas and approaches to treating addiction.

The event will involve a broad array of plenary speakers and will be providing multiple symposia within separate tracks as well as a poster session, and social events.  

ISAM & CSAM 2020 joint conference in Victoria will also offer several topical workshops.

The conference will act as a venue for researchers, educators and clinicians from different disciplines to meet, present their research, exchange ideas and collaborate on future courses.

National Drug Control Strategy, USA

This Strategy focuses on achieving one overarching strategic outcome:

 

Building a stronger, healthier, drug-free society today and in the years to come by drastically reducing the number of Americans losing their lives to drug addiction in today’s crisis, and preparing now to dominate the drug environment of the future. This will be done by preventing initiates to drug use, providing treatment services leading to long-term recovery for those suffering from addiction, and aggressively reducing the availability of illicit drugs in America’s communities.

US National Treatment Plan for Substance Use Disorder 2020

"In 2018, nearly 89% of the estimated 20.2 million Americans with a substance use disorder (SUD) did not receive specialized treatment for their condition—a disparity known as the “treatment gap”. Today, the White House Office of National Drug Control Policy is pleased to release the President’s National Drug Control Strategy and the accompanying National Treatment Plan, an evidence-based framework to increase Americans’ access to high-quality SUD treatment and support those in long-term recovery.

The Treatment Plan addresses the many reasons for this treatment gap. Many Americans cannot access treatment due to provider shortages and financial barriers, and others do not seek help because they are unaware of the severity of their drug use or are dissuaded by the stigma of addiction. The Treatment Plan supports strategies to encourage healthcare providers to screen for SUD so their patients can receive appropriate treatment. It also seeks to alleviate patients’ financial barriers by working with health insurers in the private and public sectors to pay for life-saving treatment. Additionally, it seeks to explore innovative healthcare delivery strategies like telemedicine, support strategies to build the addiction workforce, and continue to combat the stigma of addiction.

Source: https://www.whitehouse.gov/wp-content/uploads/2020/02/2020-NDCS-Treatment-Plan.pdf

Call for Team Applications: Fifteenth Annual Sloboda and Bukoski SPR Cup

Significant advances in prevention science are often due to a team of individuals working closely together across many years. In recognition of the importance of the collaborative process to the field, the Society for Prevention Research (SPR) will sponsor a friendly competition amongst teams of early career researchers for the honour of bringing home the Sloboda and Bukoski SPR Cup.

The Cup is named for two of the founders and long-time active members of SPR, Dr Zili Sloboda and Dr William Bukoski. The competition is an opportunity for a unique experience: several independent teams of scientists, each working with the same data set, problem-solve together for a brief period of time and then jointly present the results of their work to each other and to a panel of senior prevention scientists and the SPR membership.

Application Deadline: 5 p.m. Pacific time on Monday, February 24th, 2020

8th Annual Drug Prevention Summit

Join together with drug prevention professionals from across the U.S. at our 8th Annual Drug Prevention Summit on February 17th and 18th, in Tampa, Florida. Don’t miss this incredible opportunity to hear from many influential leaders, including U.S. Surgeon General, VADM Jerome M. Adams, M.D., M.P.H and Harvard Medical School Professor, Bertha K. Madras, Ph.D. To register and learn more about the summit, visit this link: http://events.r20.constantcontact.com/register/event?oeidk=a07egiquch19a188507&llr=jqecsquab

Prescription Opioid Use among Military Veterans

There is growing concern about levels of opioid misuse amongst military veterans. Conditions, such as PTSD, brain injury, and chronic pain, elevate the risk among this population.

In a recent study, conducted by psychology professor Kaston Anderson-Carpenter- a behavioural and social scientist at Michigan State University, concerning trends became apparent amongst particular groups of veterans- namely bisexual veterans and veterans over the age of 50.

The research found that:

  1. Bisexual women veterans are especially at risk for recent prescription opioid misuse.
  2. Bisexual veterans have elevated risks of prescription opioid misuse.
  3. Older veterans have lower odds of misusing prescription opioids throughout their lifetime, but have much higher odds of misusing them in the past 12 months.

These new findings should be acknowledged and used to design tailored interventions.

Anderson-Carpenter says: "No one knows the military culture better than a military veteran, so those of us in positions of power need to reach out to veteran groups to create programs and strategies which are culturally appropriate."

Anderson-Carpenter, K. D., & Rutledge, J. D. (2019). Prescription Opioid Misuse among Heterosexual versus Lesbian, Gay, and Bisexual Military Veterans: Evidence from the 2015-2017 National Survey of Drug Use and Health. Drug and alcohol dependence, 107794.